Possible applications of recombinant CD4 in the treatment of AIDS
Praglia, C.
Minerva Medica 81(9): 655-656
1990
ISSN/ISBN: 0026-4806 PMID: 2122313 Document Number: 360784
Document emailed within 1 workday
Related Documents
Holloway, C.J. 1994: Applications of recombinant DNA technology in the production of glycosylated recombinant human granulocyte colony stimulating factor European Journal of Cancer 30a Suppl 3: S2-S6Mitsuyasu, R.T. 1989: The enhanced potential use of recombinant alpha interferon in the treatment of AIDS-related Kaposi's sarcoma Oncology Nursing Forum 16(6): 5-7
Karwacki, M.; Ochocka, M.; Kubiak, W. 1994: Anemia in AIDS: the problem to avoid. Human recombinant erythropoietin in the treatment of HIV positive patients Przeglad Epidemiologiczny 48(4): 441-447
Garavelli, P.L.; Berti, P. 1993: Recombinant granulocyte colony-stimulating factor in the long-term treatment of AIDS-related neutropenias Recenti Progressi in Medicina 84(7-8): 526-530
Korwek, E.L. 1981: OSHA regulation of industrial applications of recombinant DNA technology University of Cincinnati Law Review. University of Cincinnati. College of Law 50(2): 284-313
Caligiuri, M.A. 1993: Low-dose recombinant interleukin-2 therapy: rationale and potential clinical applications Seminars in Oncology 20(6 Suppl 9: 3-10
Steinheider, G. 1988: Recombinant hemopoietic growth factors. Molecular cloning and potential therapeutic applications Arzneimittel-Forschung 38(6): 851-854
Fincke, U.; Schneider, J.; Friderichs, E.; Giertz, H.; Flohé, L. 1988: Enhanced myocardial salvage by combined treatment with recombinant single-chain urokinase-type plasminogen activator and recombinant human superoxide dismutase in a canine coronary thrombosis model Arzneimittel-Forschung 38(1): 138-142
Zarling, J.M.; Eichberg, J.W.; Moran, P.A.; McClure, J.; Sridhar, P.; Hu, S.L. 1987: Proliferative and cytotoxic T cells to AIDS virus glycoproteins in chimpanzees immunized with a recombinant vaccinia virus expressing AIDS virus envelope glycoproteins Journal of Immunology 139(4): 988-990
Reiss, P.; de Wolf, F.; Kuiken, C.L.; de Ronde, A.; Dekker, J.; Boucher, C.A.; Debouck, C.; Lange, J.M.; Goudsmit, J. 1991: Contribution of antibody response to recombinant HIV-1 gene-encoded products nef, rev, tat, and protease in predicting development of AIDS in HIV-1-infected individuals Journal of Acquired Immune Deficiency Syndromes 4(2): 165-172
Ganser, A.; Völkers, B.; Greher, J.; Hoelzer, D. 1988: Effect of recombinant human granulocyte-macrophage colony-stimulating factor on the hemopoietic progenitor cells from patients with AIDS Behring Institute Mitteilungen 83: 284-288
Lynch, M.; Yanes, L.; Todd, K. 1988: Nursing care of AIDS patients participating in a Phase I/Ii trial of recombinant human granulocyte-macrophage colony stimulating factor Oncology Nursing Forum 15(4): 463-469
al Jarallah, A.S.; Duncan, W.J.; Broecker, L.; Allen, L.; Cornel, G. 1997: The Hemopump as a left ventricular assist device in pediatric applications: initial Canadian applications Canadian Journal of Cardiology 13(5): 489-494
Levy, N.C.; Miksad, R.A.; Fein, O.T. 2005: From treatment to prevention: the interplay between HIV/AIDS treatment availability and HIV/AIDS prevention programming in Khayelitsha, South Africa Journal of Urban Health: Bulletin of the new York Academy of Medicine 82(3): 498-509
Ravi, V.; King, T.Piao.; Andersen, J.F.; Nutman, T.B.; Neva, F.A. 2005: Strongyloides stercoralis recombinant NIE antigen shares epitope with recombinant Ves v 5 and Pol a 5 allergens of insects American Journal of Tropical Medicine and Hygiene 72(5): 549-553
Talmadge, J.E.; Tribble, H.R.; Pennington, R.W.; Phillips, H.; Wiltrout, R.H. 1987: Immunomodulatory and immunotherapeutic properties of recombinant gamma-interferon and recombinant tumor necrosis factor in mice Cancer Research 47(10): 2563-2570
Wu, Z.; Wu, X.; Hou, Y. 2002: Generation of a series of recombinant herpes simplex viruses which can provide replicating and packaging functions for recombinant adeno-associated virus Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 16(1): 74-78
Char, S.; Colston, M.J.; Mitchison, N.A.; Simon, K. 1990: Purification of recombinant Mycobacterium leprae 65-kilodalton antigen and murine antibody responses to intravenously administered recombinant protein Tropical Medicine and Parasitology: Official Organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft für Technische Zusammenarbeit 41(3): 336-338
Etheridge, R.M.; Craddock, S.G.; Wechsberg, W.M. 1995: Counseling and services for HIV infection, AIDS and AIDS-risk behaviors in drug abuse treatment Findings from the NIDA drug abuse treatment outcome study PHILADELPHIA SCIENCES GROUP HIV infection in women: Setting a new agenda : P99
McMannis, J.D.; Fisher, R.I.; Creekmore, S.P.; Braun, D.P.; Harris, J.E.; Ellis, T.M. 1988: In vivo effects of recombinant IL-2. I. Isolation of circulating Leu-19+ lymphokine-activated killer effector cells from cancer patients receiving recombinant IL-2 Journal of Immunology 140(4): 1335-1340